Activated protein C improves heatstroke outcomes through restoration of normal hypothalamic and thermoregulatory function

Chien Chang Chen, Zhih Cherng Chen, Mao Tsun Lin, Chuan Chih Hsu

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

Background: Human recombinant activated protein C (APC) has been found to be beneficial in treating heatstroke in both humans and rats. Here, we further investigated the possible mechanism underlying the therapeutic action exerted by APC in experimental heatstroke. Methods: Unanesthetized and unrestrained mice were exposed to an ambient temperature of 42.4°C for 1 hour to induce heatstroke. They were given normal saline or APC (5 mg/kg of body weight, intravenously) 1 hour after the termination of heat stress. Their physiologic and biochemical parameters were continuously monitored for 4 hours after cessation of heat stress. Mice that survived on day 4 of heat treatment were considered survivors. Results: When the vehicle-treated mice underwent heat treatment, the fraction survival and core temperature at 4 hours of body heating were found to be 0 of 12 and 33.8 ± 0.6°C, respectively. Administration of APC 1 hour after the cessation of heat stress rescued the mice from heat-induced death (fraction survival, 12 of 12) and reduced hypothermia (core temperature, 37.4 ± 0.2°C). Heat-induced apoptosis in the hypothalamus was significantly reduced by APC. The increased levels of cellular ischemia (eg, glutamate, lactate-to-pyruvate ratio, nitrite, and dihydroxybenzoic acid) and damage (eg, glycerol) markers in the hypothalamus during heatstroke were also decreased significantly by APC therapy. The hypothalamic levels of tumor necrosis factor-α (a proinflammatory cytokine) that are upregulated in heat-stressed mice were significantly lower in APC-administered mice. Conclusions: Our results show that human recombinant APC improves heatstroke through restoration of normal hypothalamic and thermoregulatory function.

Original languageEnglish
Pages (from-to)382-387
Number of pages6
JournalAmerican Journal of the Medical Sciences
Volume338
Issue number5
DOIs
Publication statusPublished - Nov 2009
Externally publishedYes

Fingerprint

Heat Stroke
Protein C
Hot Temperature
Recombinant Proteins
Hypothalamus
Temperature
Survival
Nitrites
Hypothermia
Pyruvic Acid
Glycerol
Heating
Glutamic Acid
Lactic Acid
Ischemia
Tumor Necrosis Factor-alpha
Body Weight
Apoptosis
Cytokines
Acids

Keywords

  • Activated protein C
  • Apoptosis
  • Heatstroke
  • Inflammation
  • Lethality

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Activated protein C improves heatstroke outcomes through restoration of normal hypothalamic and thermoregulatory function. / Chen, Chien Chang; Chen, Zhih Cherng; Lin, Mao Tsun; Hsu, Chuan Chih.

In: American Journal of the Medical Sciences, Vol. 338, No. 5, 11.2009, p. 382-387.

Research output: Contribution to journalArticle

@article{dee809d65cd34679b1dd4e1493a0fd11,
title = "Activated protein C improves heatstroke outcomes through restoration of normal hypothalamic and thermoregulatory function",
abstract = "Background: Human recombinant activated protein C (APC) has been found to be beneficial in treating heatstroke in both humans and rats. Here, we further investigated the possible mechanism underlying the therapeutic action exerted by APC in experimental heatstroke. Methods: Unanesthetized and unrestrained mice were exposed to an ambient temperature of 42.4°C for 1 hour to induce heatstroke. They were given normal saline or APC (5 mg/kg of body weight, intravenously) 1 hour after the termination of heat stress. Their physiologic and biochemical parameters were continuously monitored for 4 hours after cessation of heat stress. Mice that survived on day 4 of heat treatment were considered survivors. Results: When the vehicle-treated mice underwent heat treatment, the fraction survival and core temperature at 4 hours of body heating were found to be 0 of 12 and 33.8 ± 0.6°C, respectively. Administration of APC 1 hour after the cessation of heat stress rescued the mice from heat-induced death (fraction survival, 12 of 12) and reduced hypothermia (core temperature, 37.4 ± 0.2°C). Heat-induced apoptosis in the hypothalamus was significantly reduced by APC. The increased levels of cellular ischemia (eg, glutamate, lactate-to-pyruvate ratio, nitrite, and dihydroxybenzoic acid) and damage (eg, glycerol) markers in the hypothalamus during heatstroke were also decreased significantly by APC therapy. The hypothalamic levels of tumor necrosis factor-α (a proinflammatory cytokine) that are upregulated in heat-stressed mice were significantly lower in APC-administered mice. Conclusions: Our results show that human recombinant APC improves heatstroke through restoration of normal hypothalamic and thermoregulatory function.",
keywords = "Activated protein C, Apoptosis, Heatstroke, Inflammation, Lethality",
author = "Chen, {Chien Chang} and Chen, {Zhih Cherng} and Lin, {Mao Tsun} and Hsu, {Chuan Chih}",
year = "2009",
month = "11",
doi = "10.1097/MAJ.0b013e3181b272ae",
language = "English",
volume = "338",
pages = "382--387",
journal = "American Journal of the Medical Sciences",
issn = "0002-9629",
publisher = "Lippincott Williams and Wilkins",
number = "5",

}

TY - JOUR

T1 - Activated protein C improves heatstroke outcomes through restoration of normal hypothalamic and thermoregulatory function

AU - Chen, Chien Chang

AU - Chen, Zhih Cherng

AU - Lin, Mao Tsun

AU - Hsu, Chuan Chih

PY - 2009/11

Y1 - 2009/11

N2 - Background: Human recombinant activated protein C (APC) has been found to be beneficial in treating heatstroke in both humans and rats. Here, we further investigated the possible mechanism underlying the therapeutic action exerted by APC in experimental heatstroke. Methods: Unanesthetized and unrestrained mice were exposed to an ambient temperature of 42.4°C for 1 hour to induce heatstroke. They were given normal saline or APC (5 mg/kg of body weight, intravenously) 1 hour after the termination of heat stress. Their physiologic and biochemical parameters were continuously monitored for 4 hours after cessation of heat stress. Mice that survived on day 4 of heat treatment were considered survivors. Results: When the vehicle-treated mice underwent heat treatment, the fraction survival and core temperature at 4 hours of body heating were found to be 0 of 12 and 33.8 ± 0.6°C, respectively. Administration of APC 1 hour after the cessation of heat stress rescued the mice from heat-induced death (fraction survival, 12 of 12) and reduced hypothermia (core temperature, 37.4 ± 0.2°C). Heat-induced apoptosis in the hypothalamus was significantly reduced by APC. The increased levels of cellular ischemia (eg, glutamate, lactate-to-pyruvate ratio, nitrite, and dihydroxybenzoic acid) and damage (eg, glycerol) markers in the hypothalamus during heatstroke were also decreased significantly by APC therapy. The hypothalamic levels of tumor necrosis factor-α (a proinflammatory cytokine) that are upregulated in heat-stressed mice were significantly lower in APC-administered mice. Conclusions: Our results show that human recombinant APC improves heatstroke through restoration of normal hypothalamic and thermoregulatory function.

AB - Background: Human recombinant activated protein C (APC) has been found to be beneficial in treating heatstroke in both humans and rats. Here, we further investigated the possible mechanism underlying the therapeutic action exerted by APC in experimental heatstroke. Methods: Unanesthetized and unrestrained mice were exposed to an ambient temperature of 42.4°C for 1 hour to induce heatstroke. They were given normal saline or APC (5 mg/kg of body weight, intravenously) 1 hour after the termination of heat stress. Their physiologic and biochemical parameters were continuously monitored for 4 hours after cessation of heat stress. Mice that survived on day 4 of heat treatment were considered survivors. Results: When the vehicle-treated mice underwent heat treatment, the fraction survival and core temperature at 4 hours of body heating were found to be 0 of 12 and 33.8 ± 0.6°C, respectively. Administration of APC 1 hour after the cessation of heat stress rescued the mice from heat-induced death (fraction survival, 12 of 12) and reduced hypothermia (core temperature, 37.4 ± 0.2°C). Heat-induced apoptosis in the hypothalamus was significantly reduced by APC. The increased levels of cellular ischemia (eg, glutamate, lactate-to-pyruvate ratio, nitrite, and dihydroxybenzoic acid) and damage (eg, glycerol) markers in the hypothalamus during heatstroke were also decreased significantly by APC therapy. The hypothalamic levels of tumor necrosis factor-α (a proinflammatory cytokine) that are upregulated in heat-stressed mice were significantly lower in APC-administered mice. Conclusions: Our results show that human recombinant APC improves heatstroke through restoration of normal hypothalamic and thermoregulatory function.

KW - Activated protein C

KW - Apoptosis

KW - Heatstroke

KW - Inflammation

KW - Lethality

UR - http://www.scopus.com/inward/record.url?scp=73649104824&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=73649104824&partnerID=8YFLogxK

U2 - 10.1097/MAJ.0b013e3181b272ae

DO - 10.1097/MAJ.0b013e3181b272ae

M3 - Article

VL - 338

SP - 382

EP - 387

JO - American Journal of the Medical Sciences

JF - American Journal of the Medical Sciences

SN - 0002-9629

IS - 5

ER -